The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test is an advanced diagnostic procedure offered by DNA Labs UAE, designed to swiftly identify the drug susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). Priced at 5500 AED, this comprehensive test covers a panel of 19 drugs, providing critical information on the resistance patterns of the tuberculosis bacteria. This enables healthcare providers to tailor the most effective treatment plans for patients, significantly improving the chances of successful outcomes. The test involves culturing the bacteria from a patient's sample to evaluate how it responds to the various drugs, ensuring precise and targeted therapy in combating TB. By incorporating this test, DNA Labs UAE plays a pivotal role in the fight against tuberculosis, especially in cases where drug-resistant TB is a concern.
The "Ophthalmology Eyes Vision Panel NGS Genetic Test" is a comprehensive genetic screening tool designed to identify genetic mutations associated with various eye conditions and vision impairments. This test utilizes Next-Generation Sequencing (NGS) technology, a cutting-edge method that allows for the detailed analysis of multiple genes simultaneously, providing insights into the genetic basis of ophthalmic diseases. Conditions that can be detected through this panel include, but are not limited to, age-related macular degeneration, glaucoma, retinitis pigmentosa, and hereditary optic neuropathies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this panel is priced at 5410 AED. DNA Labs UAE is known for its state-of-the-art technology and expertise in genetic diagnostics, offering accurate and reliable results. The test is a valuable resource for individuals with a family history of eye diseases, those experiencing symptoms of these conditions, or anyone interested in understanding their genetic predisposition to various eye and vision-related disorders. By identifying specific genetic mutations, the test can guide personalized treatment plans, preventive measures, and informed decision-making regarding eye health.
The Amyotrophic Lateral Sclerosis (ALS) Panel NGS Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a comprehensive genetic screening designed to identify mutations associated with ALS, also known as Lou Gehrig's disease. This advanced test utilizes Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, providing a detailed insight into the genetic underpinnings of this progressive neurodegenerative disorder. ALS affects motor neurons in the brain and spinal cord, leading to muscle weakness, loss of motor control, and ultimately, paralysis. The test is crucial for individuals with a family history of ALS or those exhibiting symptoms, offering vital information for diagnosis, prognosis, and potential treatment options. By pinpointing specific genetic mutations, the ALS Panel NGS Genetic Test at DNA Labs UAE aids in understanding the risk and guiding decisions regarding management and therapeutic strategies.
The Ataxia Comprehensive Panel NGS Genetic Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations associated with various forms of ataxia, a neurological disorder that affects coordination, balance, and speech. This test utilizes Next Generation Sequencing (NGS) technology, which allows for the simultaneous examination of multiple genes associated with ataxia, providing a comprehensive analysis of the patient's genetic makeup.
At a cost of 4400 AED, the test is an investment in pinpointing the specific genetic alterations that may be responsible for ataxic symptoms, facilitating a more tailored approach to treatment and management of the condition. By identifying the genetic underpinnings of ataxia, healthcare providers can offer patients more personalized care plans, potentially improving outcomes and quality of life.
DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring that patients receive accurate and reliable results. This test represents an important step forward in the field of neurogenetics and offers hope to individuals and families affected by ataxia, providing them with critical information that can guide their healthcare decisions.
The Ataxia Panel NGS (Next-Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with various forms of ataxia. Ataxia is a neurological disorder characterized by a lack of muscle coordination which can affect speech, eye movements, and the ability to swallow, walk, and perform fine motor tasks. This condition can be caused by a wide range of genetic mutations, and the Ataxia Panel NGS Genetic Test targets these mutations to provide a precise diagnosis.
Utilizing cutting-edge NGS technology, this test examines multiple genes simultaneously, offering a thorough and efficient analysis. This approach not only increases the likelihood of identifying the specific genetic cause of ataxia in a patient but also reduces the need for multiple, separate genetic tests.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost reflects the comprehensive nature of the test and the advanced technology used. Once the test is completed, patients receive a detailed report that can guide their treatment plans and provide insight into the inheritance patterns of the disorder, which is crucial for family planning and understanding the risk to future generations.
The Ataxia Repeat Expansion Panel NGS (Next-Generation Sequencing) Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with various forms of ataxia. Ataxia, a neurological condition characterized by lack of muscle control or coordination of voluntary movements, can result from mutations in specific genes. This panel targets those mutations by analyzing the DNA sequence of genes known to be associated with different types of ataxia, including spinocerebellar ataxias (SCAs), Friedreich's ataxia, and others.
Utilizing cutting-edge NGS technology, this test provides a comprehensive examination of the genetic sequences, allowing for the detection of both known and novel repeat expansions that could lead to ataxia. The accuracy and depth of analysis provided by NGS ensure a reliable diagnosis, which is crucial for the management and treatment of the condition. This is particularly important for hereditary ataxias, where early detection can significantly impact the patient's quality of life.
The cost of the Ataxia Repeat Expansion Panel NGS Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the advanced technology and expertise required to perform such a detailed genetic analysis. For patients and families affected by ataxia, this test represents a valuable resource for obtaining a precise diagnosis, understanding the genetic basis of their condition, and exploring potential treatment options based on their genetic information.
The CentoIEM NGS Genetic Test, available at DNA Labs UAE, is a comprehensive genetic testing solution designed to detect a wide range of inherited metabolic disorders. Utilizing Next-Generation Sequencing (NGS) technology, this test offers a highly accurate and efficient approach to identifying genetic variations associated with metabolic conditions. With a cost of 4400 AED, the CentoIEM NGS Genetic Test is a valuable tool for clinicians and patients aiming to understand genetic predispositions and tailor personalized treatment plans. By analyzing a patient's DNA, the test can provide insights into more than 100 different metabolic disorders, enabling early detection and intervention, which is crucial for managing these conditions effectively. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures reliable results and comprehensive support throughout the testing process.
The NGSMito Comprehensive NGS Genetic Test, offered at DNA Labs UAE for a cost of 4400 AED, is a state-of-the-art genetic screening that utilizes Next Generation Sequencing (NGS) technology to provide a detailed analysis of the mitochondrial genome. This advanced test is designed to identify mutations and variations within the mitochondrial DNA (mtDNA) that could be indicative of various mitochondrial disorders, which are often complex and can affect multiple systems in the body. Mitochondrial diseases can lead to symptoms ranging from muscle weakness and neurological issues to more severe conditions affecting organ function. The comprehensive nature of this test makes it a powerful tool for individuals seeking insights into their genetic makeup concerning mitochondrial health, potentially guiding diagnosis, treatment, and management of mitochondrial-related conditions. DNA Labs UAE ensures accuracy and reliability in their testing processes, making the NGSMito Comprehensive NGS Genetic Test a valuable resource for those looking to understand their genetic predisposition to mitochondrial diseases.
The NGSMito Genome NGS Genetic Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to provide comprehensive insights into the mitochondrial genome. Utilizing Next-Generation Sequencing (NGS) technology, this test enables the detailed analysis of the entire mitochondrial DNA (mtDNA), which is crucial for understanding various inherited diseases and conditions. Mitochondrial DNA, distinct from the nuclear DNA, is maternally inherited and plays a significant role in energy production within cells. Mutations in mtDNA can lead to a range of mitochondrial disorders that affect multiple body systems, particularly those with high energy demands such as the nervous system and muscles.
The test is priced at 4400 AED and is performed in the state-of-the-art facilities of DNA Labs UAE. It is particularly valuable for individuals seeking insights into genetic conditions affecting mitochondrial function, those with a family history of mitochondrial diseases, or anyone interested in their mitochondrial health. The NGSMito Genome NGS Genetic Test provides a powerful tool for clinicians and patients alike, offering critical information that can guide diagnosis, treatment, and management of mitochondrial-related conditions.
The NGSNeuro NGS Genetic Test, available at DNA Labs UAE, is a comprehensive genetic screening tool designed to detect genetic variations and mutations that may be linked to a wide range of neurological conditions and disorders. Utilizing Next-Generation Sequencing (NGS) technology, this test offers an in-depth analysis of genes associated with neurological health, providing vital information that can assist in the diagnosis, management, and treatment of neurogenetic disorders. Priced at 4400 AED, the test represents an investment in understanding complex neurological conditions at a molecular level, paving the way for personalized medicine approaches in neurology. DNA Labs UAE, by offering this advanced genetic testing service, positions itself at the forefront of genetic diagnostics, supporting patients and healthcare providers in navigating the complexities of neurogenetic conditions with accuracy and precision.
